| Literature DB >> 33633156 |
Marianna Ranieri1, Annarita Di Mise2, Mariangela Centrone2, Mariagrazia D'Agostino2, Stine Julie Tingskov3, Maria Venneri2, Tommaso Pellegrino2, Graziana Difonzo4, Francesco Caponio4, Rikke Norregaard3, Giovanna Valenti2, Grazia Tamma5.
Abstract
Vasopressin (AVP) increases water permeability in the renal collecting duct through the regulation of aquaporin-2 (AQP2) trafficking. Several disorders, including hypertension and inappropriate antidiuretic hormone secretion (SIADH), are associated with abnormalities in water homeostasis. It has been shown that certain phytocompounds are beneficial to human health. Here, the effects of the Olive Leaf Extract (OLE) have been evaluated using in vitro and in vivo models. Confocal studies showed that OLE prevents the vasopressin induced AQP2 translocation to the plasma membrane in MCD4 cells and rat kidneys. Incubation with OLE decreases the AVP-dependent increase of the osmotic water permeability coefficient (Pf). To elucidate the possible effectors of OLE, intracellular calcium was evaluated. OLE increases the intracellular calcium through the activation of the Calcium Sensing Receptor (CaSR). NPS2143, a selective CaSR inhibitor, abolished the inhibitory effect of OLE on AVP-dependent water permeability. In vivo experiments revealed that treatment with OLE increases the expression of the CaSR mRNA and decreases AQP2 mRNA paralleled by an increase of the AQP2-targeting miRNA-137. Together, these findings suggest that OLE antagonizes vasopressin action through stimulation of the CaSR indicating that this extract may be beneficial to attenuate disorders characterized by abnormal CaSR signaling and affecting renal water reabsorption.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33633156 PMCID: PMC7907100 DOI: 10.1038/s41598-021-83850-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379